Cytarabine dose for acute myeloid leukemia

N Engl J Med. 2011 Jun 2;364(22):2166-7; author reply 2168-9. doi: 10.1056/NEJMc1104343.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antimetabolites, Antineoplastic / administration & dosage*
  • Antimetabolites, Antineoplastic / adverse effects
  • Cytarabine / administration & dosage*
  • Cytarabine / adverse effects
  • Humans
  • Leukemia, Myeloid, Acute / drug therapy*
  • Remission Induction

Substances

  • Antimetabolites, Antineoplastic
  • Cytarabine